VC boss Anu Adebajo: I was told to temper my ambition. I’m glad I didn’t listen February 26, 2026 We dig into the memory bank of the City's great and good. Today, Anu Adebajo, CEO of Newton Venture Program, takes us through her VC career.
Family visas plummet as Mahmood targets migrant dependants February 26, 2026 The number of family-related visas plummeted over 2025 as the government clamped down on dependants joining migrant workers and students. In fresh data published by the Home Office on Thursday, it was revealed that just 67,000 visas were offered to spouses, children and other dependants of migrants. It represented a sharp 22 per cent drop [...]
Courtrooms in the cloud: How Opus 2 quietly changed the game February 26, 2026 AI is making its mark on the legal profession, an industry renowned for its cautious approach to change. Yet, behind the scenes, innovative technologies have been quietly transforming courtrooms for years. If you ever sat behind the row of barristers and the lawyers that instructed them in a courtroom at the High Court, you may [...]
On this day: The collapse of Barings Bank February 26, 2026 On 26 February 1995, 31 years ago today, Baring Bank, one of the City’s most venerable institutions, was declared insolvent after a massive fraud by one of its employees, Nick Leeson, recalls Eliot Wilson In the 1990s, following the wake of Big Bang and the influx of brash but wealthy, “Greed is good, greed is [...]
Amadeus Acquires SkyLink to Accelerate the Deployment of AI in Travel February 25, 2026 As the industry moves from AI proof of concepts to adoption, Amadeus takes the next step in delivering meaningful AI use cases at scale with the acquisition of SkyLink Amadeus to enable smarter, more automated and faster travel bookings by adding SkyLink’s AI-driven conversational technology to its product portfolio to assist travelers and employees on the road
ViiV Healthcare presents pipeline data for two investigational HIV treatment therapies with potential for twice-yearly dosing February 25, 2026 VH184, the first, third‑generation integrase inhibitor in development shows potential for up to twice-yearly dosing intervals Additional in-vitro data on VH184 demonstrate improved potency and an enhanced resistance profile versus bictegravir VH499 demonstrates good tolerability, supporting twice-yearly dosing intervals
Extend Launches CIP: a Cultural Intelligence Platform Empowering Marketers to Plan, Manage, and Monitor Campaigns Directly Through Its Marketing Platform February 25, 2026 Extend CIP unifies years of product and agency experience into a single platform for marketers across the Arab world, launching with the region's largest influencer ad library and end-to-end campaign tools
Orbia Announces CFO Transition and Appointment of Successor February 25, 2026 Orbia Advance Corporation, S.A.B. de C.V. (BMV: ORBIA*) (“Orbia” or “the Company”) announced today that James P. “Jim” Kelly will retire as Chief Financial Officer after four years of service. The Company also announced that Cristian “Cape” Capellino will assume the role of Chief Financial Officer effective March 15, 2026. Kelly joined Orbia in 2021 [...]
Aera Technology Named to The Hackett Group® 2025–2026 “50 to Watch” List for Procurement Innovation February 25, 2026 Recognized for Enabling Real-Time Procurement Decisions Across the Enterprise
Alkermes plc Announces CEO Succession Plan February 25, 2026 — Richard Pops to Retire from Role of Chief Executive Officer Following Distinguished 35-year Career with Alkermes — — Board of Directors Appointed Blair Jackson, Alkermes’ Current Executive Vice President, Chief Operating Officer, as CEO Effective as of August 1, 2026 — — Richard Pops to Continue to Serve as Chairman of the Alkermes Board of Directors —